Can you provide the upcoming earnings date for QUIPT HOME MEDICAL CORP?
QUIPT HOME MEDICAL CORP (QIPT.CA) will report earnings on 2022-02-07.
QUIPT HOME MEDICAL CORP (QIPT.CA) Forecast, Price Target & Analyst Ratings
TSX-V:QIPT • CA74880P1045
Current stock price
4.98 CAD
+0.02 (+0.4%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for QUIPT HOME MEDICAL CORP (QIPT.CA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of CA$4.98 to mean target of N/A, Based on 13 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
81.54%
QIPT.CA was analyzed by 13 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about QIPT.CA.
In the previous month the buy percentage consensus was at a similar level.
QIPT.CA was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-08-17 | Raymond James Capital | Upgrade | Outperform |
| 2022-04-28 | Raymond James Capital | Initiate | Outperform |
| 2022-03-24 | Colliers Securities | Initiate | Buy |
| 2022-02-16 | Raymond James Capital | Initiate | Outperform |
| 2022-01-31 | Raymond James Financial | Initiate | Outperform |
| 2021-12-20 | Canaccord Genuity | Downgrade | Buy |
| 2021-12-17 | Raymond James Financial | Initiate | Outperform |
| 2021-11-24 | RaymondJamesFinancial | Initiate | Outperform |
| 2021-11-19 | CanaccordFinancial | Upgrade | Buy |
| 2021-08-25 | Raymond James Financial | Initiate | Outperform |
| 2021-06-02 | Raymond James Financial | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Feb 7, 2022
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
Full Analyst Estimates 2023 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 72.639M 19.59% | 102.351M 40.90% | 139.862M 36.65% | 214.81M 53.59% | 246.86M 14.92% | 350.47M 41.97% | 456.48M 30.25% | 547.75M 19.99% | |
| EBITDA YoY % growth | 15.211M 59.43% | 16.465M 8.24% | 28.613M 73.78% | 47.185M 64.91% | 57.088M 20.99% | 75.346M 31.98% | 100.38M 33.23% | 123.25M 22.78% | |
| EBIT YoY % growth | 673K 171.71% | -1.321M -296.29% | 5.573M 521.88% | 8.225M 47.59% | 20.32M 147.05% | 39.996M 96.83% | 62.942M 57.37% | 85.811M 36.33% | |
| Operating Margin | 0.93% | -1.29% | 3.98% | 3.83% | 8.23% | 11.41% | 13.79% | 15.67% | |
| EPS YoY % growth | -0.18 -90.43% | 0.18 201.93% | 0.13 -27.79% | 0.15 15.57% | 0.26 73.67% | 0.68 159.36% | 1.18 74.91% | 1.69 42.79% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
QUIPT HOME MEDICAL CORP / QIPT.CA Forecast FAQ
How do analysts rate QUIPT HOME MEDICAL CORP (QIPT.CA)?
The consensus rating for QUIPT HOME MEDICAL CORP (QIPT.CA) is 81.5385 / 100 . This indicates that analysts generally have a positive outlook on the stock.